Keyphrases
Indonesia
100%
Preeclampsia
94%
Surabaya
66%
Pregnant Women
60%
Endometriosis
46%
COVID-19
39%
Polycystic Ovary Syndrome
32%
Mouse Model
28%
Maternal Death
27%
Maternal Mortality
23%
Risk Factors
23%
Meta-analysis
22%
Systematic Meta-analysis
22%
Tertiary Referral Hospital
21%
During Pregnancy
20%
General Hospital
20%
COVID-19 Pandemic
20%
Cesarean Section (C-section)
19%
Treatment Group
19%
Medical Records
18%
Infertility
17%
Tumor Necrosis Factor-α
16%
Tertiary Hospital
16%
Early Detection
15%
East Java Indonesia
15%
Pregnant Rats
14%
Soluble Fms-like Tyrosine kinase-1 (sFlt-1)
14%
Confidence Interval
14%
Cervical Cancer
14%
Indonesian
14%
Obstetrics and Gynaecology
13%
Disease-free Survival
13%
Cervical Cancer Patients
13%
Maternal Outcomes
13%
Chemotherapy
12%
High-risk Pregnancy
12%
Academic Hospital
12%
Placenta Accreta Spectrum
12%
Rattus Norvegicus
12%
Gestational Diabetes Mellitus
12%
Antenatal Care
12%
Folliculogenesis
11%
Rat Model
11%
Cesarean Delivery
11%
Inclusion Criteria
11%
Quality of Life
11%
Vaginal Delivery
11%
Interleukin-6
11%
Mode of Delivery
10%
Insulin Resistance
10%
Pregnancy Outcome
10%
COVID-19 Infection
10%
Obesity
10%
Midwives
10%
Factor Level
10%
Atorvastatin
9%
Hysterectomy
9%
Neonatal Outcome
9%
Referral Hospital
9%
East Java
9%
Pelvic Organ Prolapse
9%
High Risk
9%
Indonesian Women
9%
No Significant Difference
8%
Vesicovaginal Fistula
8%
Syndrome Model
8%
Mus musculus
8%
Placenta
8%
Odds Ratio
8%
Maternal Mortality Rate
8%
PubMed
8%
Obstetrics
8%
Endothelial Dysfunction
8%
Perinatal Outcome
8%
Sexual Behavior
8%
Infertile Women
7%
Inflammatory Cytokines
7%
Third Trimester
7%
Clinical Characteristics
7%
COVID-19 Cases
7%
Postpartum Women
7%
Non-endemic
7%
Syzygium Polyanthum (Wight) Walp
7%
Arginine
7%
Andrographis Paniculata
7%
Cervical Cancer Prevention
7%
Regular Exercise
7%
High-protein Diet
7%
Cervical Cancer Screening
7%
Vaginal Laxity
7%
Placental Growth Factor (PlGF)
7%
Apoptotic Index
6%
Female Mice
6%
Universitas
6%
Peritoneal Fluid
6%
Serum Levels
6%
Hypertension
6%
Statistical Analysis
6%
Overall Survival
6%
Uterus
6%
Medicine and Dentistry
Pre-Eclampsia
74%
COVID-19
48%
Patient Referral
39%
Cesarean Section
28%
Obstetrics
25%
Maternal Death
24%
Systematic Review
22%
Maternal Mortality
22%
Endometriosis
19%
Infection
19%
Medical Record
18%
Cervical Cancer
18%
Diseases
16%
Tumor Necrosis Factor
14%
Disease Free Survival
14%
Vaginal Delivery
14%
Placenta Accreta
13%
Gynecology
11%
Prenatal Care
11%
Hysterectomy
10%
Polycystic Ovary Syndrome
9%
Amnion
9%
Pelvic Organ Prolapse
9%
Cross Sectional Study
9%
Vesicovaginal Fistula
9%
Retrospective Study
9%
Body Mass Index
8%
Gestational Diabetes
8%
Placenta
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Observational Study
8%
Malignant Neoplasm
8%
Eclampsia
8%
Neoplasm
8%
Wart Virus
8%
Programmed Cell Death
8%
Diabetes Mellitus
8%
Primary Health Care
7%
Krukenberg Tumor
7%
Meta-Analysis
7%
Third Trimester Pregnancy
7%
Maternal Welfare
7%
Mesenchymal Stem Cell
7%
Arginine
7%
Erbium
7%
Amniotic Stem Cell
7%
Recurrent Disease
7%
Pelvis
7%
Health Service
7%
Female Genital Tract Cancer
6%
Screening
6%
Cervical Cancer Screening
6%
Ovarian Tumor
6%
Overall Survival
6%
Umbilical Cord-Derived Mesenchymal Stem Cell
6%
Wart Virus Vaccine
6%
Outpatient
6%
Cohort Analysis
6%
Proteinuria
5%
Quality of Life
5%
Endothelial Dysfunction
5%
Abdominal Hysterectomy
5%
Biological Marker
5%
Mortality Rate
5%
Ovarian Cancer
5%
Bleeding
5%
Cervical Cancer Prevention
5%
Uterine Fibroid
5%
Gynecological Oncology
5%
Heart Disease
5%
Premature Labor
5%
Diabetes
5%
Prognostic Factor
5%
Blood Pressure
5%
Prevalence
5%
Carbon Dioxide
5%
Manikin
5%
Side Effect
5%